Design and discovery of new potential dual kinase back-pocket binders by fragmentation and virtual screening of natural products

The discovery of new and better drugs is a costly and slow process in which the identification of optimal preclinical candidates is often a difficult task. To overcome this drawback, fragment based drug design (FBDD), virtual screening (VS) and the use of natural products (NP) have become powerful s...